Metabolomic Mapping of Atypical Effects in Schizophrenia
Publication
, Conference
Kaddurah-Daouk, R; Baillie, RA; McEvoy, J
Published in: DRUG METABOLISM REVIEWS
2009
Duke Scholars
Published In
DRUG METABOLISM REVIEWS
ISSN
0360-2532
Publication Date
2009
Volume
41
Start / End Page
22 / 23
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kaddurah-Daouk, R., Baillie, R. A., & McEvoy, J. (2009). Metabolomic Mapping of Atypical Effects in Schizophrenia. In DRUG METABOLISM REVIEWS (Vol. 41, pp. 22–23).
Kaddurah-Daouk, Rima, Rebecca A. Baillie, and Joseph McEvoy. “Metabolomic Mapping of Atypical Effects in Schizophrenia.” In DRUG METABOLISM REVIEWS, 41:22–23, 2009.
Kaddurah-Daouk R, Baillie RA, McEvoy J. Metabolomic Mapping of Atypical Effects in Schizophrenia. In: DRUG METABOLISM REVIEWS. 2009. p. 22–3.
Kaddurah-Daouk, Rima, et al. “Metabolomic Mapping of Atypical Effects in Schizophrenia.” DRUG METABOLISM REVIEWS, vol. 41, 2009, pp. 22–23.
Kaddurah-Daouk R, Baillie RA, McEvoy J. Metabolomic Mapping of Atypical Effects in Schizophrenia. DRUG METABOLISM REVIEWS. 2009. p. 22–23.
Published In
DRUG METABOLISM REVIEWS
ISSN
0360-2532
Publication Date
2009
Volume
41
Start / End Page
22 / 23
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences